NANOVIRICIDES, INC. 4
4 · NANOVIRICIDES, INC. · Filed Feb 24, 2014
Insider Transaction Report
Form 4
Diwan Anil
DirectorPresident10% Owner
Transactions
- Purchase
Common Stock
2014-02-18$3.58/sh+10,000$35,800→ 1,976,347 total - Purchase
Common Stock
2014-02-18$3.57/sh+5,000$17,850→ 1,986,347 total - Purchase
Common Stock
2014-02-18$3.62/sh+5,000$18,100→ 1,996,347 total - Purchase
Common Stock
2014-02-18$3.52/sh+5,000$17,600→ 2,001,347 total - Purchase
Common Stock
2014-02-20$3.80/sh+15,000$57,000→ 2,016,347 total - Purchase
Common Stock
2014-02-18$3.30/sh+5,000$16,500→ 1,981,347 total - Purchase
Common Stock
2014-02-18$3.55/sh+5,000$17,750→ 1,991,347 total
Footnotes (1)
- [F1]Includes 285,714 shares issuable upon exercise of options. Does not include 285,714 shares of the Company's Series A Convertible Preferred Stock ("Series A") or 9,531,429 shares of common stock and 2,050,000 shares of Series A owned by TheraCour Pharma, Inc., over which Dr. Diwan holds voting and dispositive power.